[go: up one dir, main page]

WO2008122667A3 - Dérivés d'uréylène - Google Patents

Dérivés d'uréylène Download PDF

Info

Publication number
WO2008122667A3
WO2008122667A3 PCT/EP2008/054362 EP2008054362W WO2008122667A3 WO 2008122667 A3 WO2008122667 A3 WO 2008122667A3 EP 2008054362 W EP2008054362 W EP 2008054362W WO 2008122667 A3 WO2008122667 A3 WO 2008122667A3
Authority
WO
WIPO (PCT)
Prior art keywords
ureylene
derivatives
compounds
therapy
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/054362
Other languages
English (en)
Other versions
WO2008122667A2 (fr
Inventor
John Edward Moses
Stephen Neidle
Adam Donald Moorhouse
Michael Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of WO2008122667A2 publication Critical patent/WO2008122667A2/fr
Publication of WO2008122667A3 publication Critical patent/WO2008122667A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne des composés de la formule (I) ou un sel, un solvate ou un promédicament de ces derniers. Les composés précités peuvent être utilisés en thérapie, en particulier dans la thérapie anticancéreuse.
PCT/EP2008/054362 2007-04-10 2008-04-10 Dérivés d'uréylène Ceased WO2008122667A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0706932.1A GB0706932D0 (en) 2007-04-10 2007-04-10 Ureylene derivatives
GB0706932.1 2007-04-10

Publications (2)

Publication Number Publication Date
WO2008122667A2 WO2008122667A2 (fr) 2008-10-16
WO2008122667A3 true WO2008122667A3 (fr) 2009-04-09

Family

ID=38091133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/054362 Ceased WO2008122667A2 (fr) 2007-04-10 2008-04-10 Dérivés d'uréylène

Country Status (2)

Country Link
GB (1) GB0706932D0 (fr)
WO (1) WO2008122667A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010138079A (ja) * 2008-12-09 2010-06-24 Mitsui Chemicals Inc アミド誘導体および殺虫剤
GB201105751D0 (en) 2011-04-05 2011-05-18 Univ London Pharmacy G-quadruplex stabilising agent
US10738016B2 (en) 2015-10-13 2020-08-11 H. Lee Moffitt Cancer Center And Research Institute, Inc. BRD4-kinase inhibitors as cancer therapeutics
CN118290341B (zh) * 2024-03-29 2024-10-18 国王医学科技(山东)有限公司 一种具有抗肿瘤活性的脲类化合物、制备方法及应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116729A2 (fr) * 1983-01-24 1984-08-29 Duphar International Research B.V Dérivés de benzoylurées et les compositions pesticides renfermant ces composés
JPS6434953A (en) * 1987-07-30 1989-02-06 Agro Kanesho Co Ltd Benzoylurea based compound and acaricide and insecticide containing said compound as active ingredient
WO2000042012A1 (fr) * 1999-01-13 2000-07-20 Bayer Corporation DIPHENYLUREES A SUBSTITUANTS φ-CARBOXYARYLES, INHIBITRICES DE KINASE RAF
WO2004007437A1 (fr) * 2002-07-11 2004-01-22 Aventis Pharma Deutschland Gmbh Acylurees substituees par uree et urethane, procedes permettant de les produire et leur utilisation comme medicaments
FR2850970A1 (fr) * 2003-02-07 2004-08-13 Aventis Pharma Sa Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique
WO2005051366A2 (fr) * 2003-11-28 2005-06-09 Novartis Ag Derives de diaryluree utilises en traitement de maladies dependant de proteines kinases
WO2006049941A2 (fr) * 2004-10-27 2006-05-11 Neurogen Corporation Diaryl urees, antagonistes du cb1
EP1724258A1 (fr) * 2004-02-23 2006-11-22 Chugai Seiyaku Kabushiki Kaisha Derive d'heteroarylphenyluree

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116729A2 (fr) * 1983-01-24 1984-08-29 Duphar International Research B.V Dérivés de benzoylurées et les compositions pesticides renfermant ces composés
JPS6434953A (en) * 1987-07-30 1989-02-06 Agro Kanesho Co Ltd Benzoylurea based compound and acaricide and insecticide containing said compound as active ingredient
WO2000042012A1 (fr) * 1999-01-13 2000-07-20 Bayer Corporation DIPHENYLUREES A SUBSTITUANTS φ-CARBOXYARYLES, INHIBITRICES DE KINASE RAF
WO2004007437A1 (fr) * 2002-07-11 2004-01-22 Aventis Pharma Deutschland Gmbh Acylurees substituees par uree et urethane, procedes permettant de les produire et leur utilisation comme medicaments
FR2850970A1 (fr) * 2003-02-07 2004-08-13 Aventis Pharma Sa Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique
WO2005051366A2 (fr) * 2003-11-28 2005-06-09 Novartis Ag Derives de diaryluree utilises en traitement de maladies dependant de proteines kinases
EP1724258A1 (fr) * 2004-02-23 2006-11-22 Chugai Seiyaku Kabushiki Kaisha Derive d'heteroarylphenyluree
WO2006049941A2 (fr) * 2004-10-27 2006-05-11 Neurogen Corporation Diaryl urees, antagonistes du cb1

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DUMAS J: "PROTEIN KINASE INHIBITORS FROM THE UREA CLASS", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, vol. 5, no. 5, 1 January 2002 (2002-01-01), pages 718 - 727, XP009011493, ISSN: 1367-6733 *

Also Published As

Publication number Publication date
GB0706932D0 (en) 2007-05-16
WO2008122667A2 (fr) 2008-10-16

Similar Documents

Publication Publication Date Title
IL206286A0 (en) Thiazole derivatives used as pi 3 kinase inhibitors
IL201973A0 (en) 3,3-spiroindolinone derivatives
IL224109A (en) Isoxazole derivatives for use as fungicides
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
WO2008083248A3 (fr) Analogues de cyclopamine
WO2008101682A3 (fr) Nouveaux microbiocides
ZA200904108B (en) Pyrido-pyrazine derivatives useful as herbicidal compounds
WO2008110355A8 (fr) Dérivés de quinoléine en tant que fongicides
ZA201001797B (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
SI2201012T1 (sl) Derivati pirolo(2,3-D)pirimidina kot inhibitorji proteina kinaze B
WO2009024342A3 (fr) Nouveaux microbiocides
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
IL204563A0 (en) Thiazole derivatives
ZA201002217B (en) 1,3-dihydroisoindole derivatives
EP1940843A4 (fr) Derives heterocycliques insatures
WO2008151828A8 (fr) Nouveaux microbiocides
IL209423A0 (en) 4,5-dihydro-oxazol-2-yl derivatives
ZA200906462B (en) Hydrochloride salt of 5-[-3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2, 2-diphenylhexanamide
WO2008155666A3 (fr) Dérivés de pyrimidone hétéroarylamide
WO2009003672A3 (fr) Nouveaux microbiocides
WO2008122667A3 (fr) Dérivés d'uréylène
IL223327A0 (en) 5,6 or 7-substituted-s- (hetero) arylisoquinolinamine derivatives as antitumor agents
ZA200907014B (en) New 4,8-diphenyl-polyazanaphthalene derivatives
ZA200907389B (en) Fungicides phenyl-pyrimdinyl-amino derivatives
WO2009111028A8 (fr) Inhibiteur de l’aurora kinase

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08749535

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08749535

Country of ref document: EP

Kind code of ref document: A2